Skip to main content
Yifeng Pharmacy Chain Co., Ltd. logo

Yifeng Pharmacy Chain Co., Ltd. — Investor Relations & Filings

Ticker · 603939 ISIN · CNE100001TS5 LEI · 300300CZZIF44N1EZO06 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,865 across all filing types
Latest filing 2023-10-25 Transaction in Own Shar…
Country CN China
Listing Shanghai Stock Exchange 603939

About Yifeng Pharmacy Chain Co., Ltd.

https://www.yfdyf.cn/

Yifeng Pharmacy Chain Co., Ltd. operates as a large-scale retail pharmacy enterprise. The company specializes in the distribution and sale of prescription drugs, over-the-counter medicines, traditional Chinese medicine, nutritional supplements, and medical devices. It utilizes a standardized management system across its extensive network of retail stores to ensure service quality and operational efficiency. Beyond physical retail, the company has developed a comprehensive digital healthcare ecosystem, integrating online-to-offline (O2O) services to provide professional pharmaceutical consultations and health management solutions. Its business model focuses on a "big health" strategy, aiming to provide accessible healthcare products and professional services to a broad consumer base through optimized supply chain logistics and a diversified product portfolio.

Recent filings

Filing Released Lang Actions
益丰药房高级管理人员集中竞价减持股份结果公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement regarding the results of a share reduction (share sale) by senior management personnel of the company. It details the number of shares held before and after the reduction, the reduction plan, and the completion status of the reduction. It does not contain financial statements or performance data, nor is it a report or presentation. The content fits the definition of a 'Transaction in Own Shares' filing, which reports on the company's insiders selling their shares. The document length is short and focused solely on share transactions by executives, confirming it is not a full report or announcement of a report publication.
2023-10-25 Chinese
益丰药房关于参加2023年湖南辖区上市公司投资者网上集体接待日活动的公告
Regulatory Filings Classification · 95% confidence The document is an announcement about the company's participation in an investor online collective reception day event organized by regulatory and industry bodies. It mentions that company management will communicate with investors about the 2022 annual performance, governance, strategy, financing plans, and other topics. The document is short (609 characters) and serves as a notice of an upcoming investor interaction event rather than a detailed report or transcript. It does not contain financial statements or detailed financial data. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and miscellaneous filings that do not fit other categories.
2023-10-23 Chinese
益丰药房第四届董事会第三十二次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 32nd meeting of the 4th Board of Directors of Yifeng Pharmacy Chain Co., Ltd. It details the meeting date, attendance, voting results, and specific agenda items such as the unlocking of restricted stock under the 2022 stock incentive plan. The content focuses on board decisions and approvals rather than financial results, audit opinions, or shareholder voting outcomes. It is not an annual report, earnings release, or regulatory filing of financial data. The document fits the category of Board/Management Information (MANG) as it announces board meeting resolutions and related corporate governance matters.
2023-10-17 Chinese
益丰药房第四届监事会第二十七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of a resolution passed at the 27th meeting of the 4th Supervisory Board of Yifeng Pharmacy Chain Co., Ltd. It details the meeting attendance, voting results, and approval of a stock incentive plan unlocking. The content is about a board-level decision and meeting resolution, not a full report or financial statement. It is not an annual or interim report, earnings release, or audit report. It is not a shareholder voting result announcement for a general meeting, but a supervisory board meeting resolution. Therefore, it fits best under Board/Management Information (MANG). The document length is short and focused on management decisions, consistent with MANG filings.
2023-10-17 Chinese
独立董事关于第四届董事会第三十二次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from the independent directors of the company regarding a specific board meeting agenda item related to the 2022 restricted stock incentive plan and its first unlocking period. It references compliance with laws and regulations and confirms the legitimacy of the stock incentive plan and the unlocking conditions. The document is short (665 characters) and focuses on a specific board matter rather than a full report or financial statements. It is not an annual report, audit report, earnings release, or any financial report. It is also not a general regulatory filing or announcement of a report. The content fits best under Board/Management Information (MANG) as it relates to board meeting matters and independent directors' opinions on company governance issues.
2023-10-17 Chinese
益丰药房关于2022年限制性股票激励计划首次授予第一个解除限售期解除限售条件成就暨股份上市的公告
Share Issue/Capital Change Classification · 95% confidence The document is an official announcement from a company regarding the unlocking and listing of restricted shares under a 2022 restricted stock incentive plan. It details the approval and implementation of the stock incentive plan, the unlocking conditions, the number of shares unlocked, and the legal and supervisory opinions on the unlocking. The document is focused on the stock incentive plan and the unlocking of shares, which is a capital change event related to share issuance and circulation. It is not a full financial report, earnings release, or management discussion. It is also not a simple announcement of a report publication but a substantive announcement about share unlocking and listing. Therefore, the document fits best under the category of Share Issue/Capital Change (SHA). The document length is over 5,000 characters and contains detailed information about the share unlocking event, supporting a high confidence classification.
2023-10-17 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.